{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:17:42Z","timestamp":1792700262068,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930108"],"award-info":[{"award-number":["81930108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970323"],"award-info":[{"award-number":["81970323"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271347"],"award-info":[{"award-number":["82271347"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.intimp.2023.110139","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T18:56:31Z","timestamp":1682362591000},"page":"110139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Tetrandrine alleviates atherosclerosis via inhibition of STING-TBK1 pathway and inflammation in macrophages"],"prefix":"10.1016","volume":"119","author":[{"given":"Weixin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaojun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","article-title":"Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease","volume":"118","author":"Herrington","year":"2016","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.intimp.2023.110139_b0010","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.intimp.2023.110139_b0015","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/pharmrev.120.000096","article-title":"Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies","volume":"73","author":"Xu","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.intimp.2023.110139_b0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage phenotype and function in different stages of atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110139_b0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/cvr\/cvy293","article-title":"Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology","volume":"115","author":"Tu\u00f1\u00f3n","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.intimp.2023.110139_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/hvaa275","article-title":"Inflammation in atherosclerosis\u2014no longer a theory","volume":"67","author":"Libby","year":"2021","journal-title":"Clin. Chem."},{"issue":"20","key":"10.1016\/j.intimp.2023.110139_b0045","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/CIRCULATIONAHA.117.030484","article-title":"Inflammation and atherosclerosis: the end of a controversy","volume":"136","author":"Hansson","year":"2017","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.intimp.2023.110139_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis\u2014from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrcardio.2015.5","article-title":"Anti-inflammatory therapies for atherosclerosis","volume":"12","author":"B\u00e4ck","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.intimp.2023.110139_b0060","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.intimp.2023.110139_b0065","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41551-020-00675-9","article-title":"Prolonged activation of innate immune pathways by a polyvalent STING agonist","volume":"5","author":"Li","year":"2021","journal-title":"Nat. Biomed. Eng."},{"issue":"1","key":"10.1016\/j.intimp.2023.110139_b0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.immuni.2020.05.013","article-title":"Structures and mechanisms in the cGAS-STING innate immunity pathway","volume":"53","author":"Zhang","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2023.110139_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08620-4","article-title":"Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression","volume":"10","author":"Lama","year":"2019","journal-title":"Nat. Commun."},{"issue":"7748","key":"10.1016\/j.intimp.2023.110139_b0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41586-019-1000-2","article-title":"Structural basis of STING binding with and phosphorylation by TBK1","volume":"567","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.intimp.2023.110139_b0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"42","key":"10.1016\/j.intimp.2023.110139_b0090","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1093\/eurheartj\/ehab249","article-title":"STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases","volume":"42","author":"Pham","year":"2021","journal-title":"Eur. Heart J."},{"issue":"16","key":"10.1016\/j.intimp.2023.110139_b0095","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-5548","article-title":"Tetrandrine mediates renal function and redox homeostasis in a streptozotocin-induced diabetic nephropathy rat model through Nrf2\/HO-1 reactivation","volume":"8","author":"Su","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.intimp.2023.110139_b0100","doi-asserted-by":"crossref","first-page":"e2786","DOI":"10.1002\/brb3.2786","article-title":"Tetrandrine alleviates inflammation and neuron apoptosis in experimental traumatic brain injury by regulating the IRE1\u03b1\/JNK\/CHOP signal pathwa","author":"Liu","year":"2022","journal-title":"Brain Behav."},{"issue":"6","key":"10.1016\/j.intimp.2023.110139_b0105","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.3892\/mmr.2016.5132","article-title":"Tetrandrine ameliorates sevoflurane-induced cognitive impairment via the suppression of inflammation and apoptosis in aged rats","volume":"13","author":"Ma","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2023.110139_b0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-8741(99)00141-5","article-title":"Anti-inflammatory effects of fangchinoline and tetrandrine","volume":"69","author":"Choi","year":"2000","journal-title":"J. Ethnopharmacol."},{"issue":"40","key":"10.1016\/j.intimp.2023.110139_b0115","doi-asserted-by":"crossref","first-page":"e202207175","DOI":"10.1002\/anie.202207175","article-title":"Novel poxin stable cGAMP-derivatives are remarkable STING agonists","volume":"61","author":"Stazzoni","year":"2022","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0120","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.18632\/aging.202491","article-title":"Synergistic inflammatory signaling by cGAS may be involved in the development of atherosclerosis","volume":"13","author":"Lu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.intimp.2023.110139_b0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1042\/CS20220525","article-title":"Cigarette smoke induces mitochondrial DNA damage and activates cGAS-STING pathway: application to a biomarker for atherosclerosis","volume":"137","author":"Ueda","year":"2023","journal-title":"Clin. Sci. (Lond)"},{"issue":"10","key":"10.1016\/j.intimp.2023.110139_b0130","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","article-title":"Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid","volume":"190","author":"Conlon","year":"2013","journal-title":"J. Immunol."},{"issue":"7713","key":"10.1016\/j.intimp.2023.110139_b0135","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2023.110139_b0140","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3389\/fcell.2021.687169","article-title":"TDP43 exacerbates atherosclerosis progression by promoting inflammation and lipid uptake of macrophages","volume":"9","author":"Huangfu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110139_b0145","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s11010-021-04061-0","article-title":"Mitochondrial DAMPs and altered mitochondrial dynamics in OxLDL burden in atherosclerosis","volume":"476","author":"Khwaja","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2023.110139_b0150","article-title":"Tetrandrine attenuated doxorubicin-induced acute cardiac injury in mice","volume":"2020","author":"Li","year":"2020","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.intimp.2023.110139_b0155","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2559.1990.tb00794.x","article-title":"Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis","volume":"17","author":"Ramshaw","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.intimp.2023.110139_b0160","doi-asserted-by":"crossref","unstructured":"J. Davignon, P. Ganz, Role of endothelial dysfunction in atherosclerosis, Circulation 109(23_suppl_1) (2004) III-27\u2013III-32.","DOI":"10.1161\/01.CIR.0000131515.03336.f8"},{"issue":"13","key":"10.1016\/j.intimp.2023.110139_b0165","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1161\/01.CIR.99.13.1740","article-title":"Intraperitoneal administration of anti\u2013c-fms monoclonal antibody prevents initial events of atherogenesis but does not reduce the size of advanced lesions in apolipoprotein E\u2013deficient mice","volume":"99","author":"Murayama","year":"1999","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.intimp.2023.110139_b0170","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.ATV.0000019051.88366.9C","article-title":"Propagermanium reduces atherosclerosis in apolipoprotein E knockout mice via inhibition of macrophage infiltration","volume":"22","author":"Yamashita","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2023.110139_b0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.carpath.2013.01.003","article-title":"Vascular fibrosis in atherosclerosis","volume":"22","author":"Lan","year":"2013","journal-title":"Cardiovasc. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110139_b0180","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCULATIONAHA.118.038379","article-title":"RIPK1 expression associates with inflammation in early atherosclerosis in humans and can be therapeutically silenced to reduce NF-\u03baB activation and atherogenesis in mice","volume":"143","author":"Karunakaran","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2023.110139_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-09588-x","article-title":"Major vault protein suppresses obesity and atherosclerosis through inhibiting IKK\u2013NF-\u03baB signaling mediated inflammation","volume":"10","author":"Ben","year":"2019","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.intimp.2023.110139_b0190","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-\u03baB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.intimp.2023.110139_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.intimp.2016.04.039","article-title":"Tetrandrine regulates hepatic stellate cell activation via TAK1 and NF-\u03baB signaling","volume":"36","author":"Li","year":"2016","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110139_b0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.imlet.2008.10.001","article-title":"Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-\u03baB activation","volume":"121","author":"Feng","year":"2008","journal-title":"Immunol. Lett."},{"issue":"9","key":"10.1016\/j.intimp.2023.110139_b0205","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/jor.23155","article-title":"Tetrandrine suppresses articular inflammatory response by inhibiting pro-inflammatory factors via NF-\u03baB inactivation","volume":"34","author":"Gao","year":"2016","journal-title":"J. Orthop. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.110139_b0210","doi-asserted-by":"crossref","first-page":"e0173725","DOI":"10.1371\/journal.pone.0173725","article-title":"Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt\/NF-\u03baB\/MMP-9 signaling","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"issue":"7713","key":"10.1016\/j.intimp.2023.110139_b0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2023.110139_b0220","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1021\/acs.joc.9b02666","article-title":"Discovery of small-molecule cyclic GMP-AMP synthase inhibitors","volume":"85","author":"Padilla-Salinas","year":"2019","journal-title":"J. Org. Chem."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923004605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:25:52Z","timestamp":1785770752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923004605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":44,"alternative-id":["S1567576923004605"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110139","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrandrine alleviates atherosclerosis via inhibition of STING-TBK1 pathway and inflammation in macrophages","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110139"}}